Vaccinia Capping Enzyme

Vaccinia virus capping enzyme is derived from a recombinant E. coli strain carries the genes for the Vaccinia capping enzyme. This single enzyme is composed of two subunits (D1 and D12) and has three enzymatic activities (RNA triphosphatase and guanylyl transferase by the D1 subunit and guanine methyltransferase by the D12 subunit). Vaccinia virus Capping Enzyme is effective to catalyze the formation of cap structure, which can specifically attach the 7-methylguanylate cap structure (m7Gppp, Cap 0) to the 5′ end of RNA. Cap structure (Cap 0) plays an important role in mRNA stabilization, transport, and translation in eukaryotes. Capping RNA by the enzymatic reaction is an effective and simple method which can significantly improve the stability and translation of RNA for in vitro transcription, transfection, and microinjection.

Product component

Storage

-20℃ for storage（Avoid repeated freeze-thaw cycles）

Storage buffer

20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM DTT, 0.1mM EDTA, 0.1% Triton X-100, 50% glycerol.

Unit Definition

One unit of Vaccinia virus Capping Enzyme is defined as the amount of enzyme required to incorporate 10 pmol of GTP into an 80 nt transcript in 1 hour at 37°C.

Quality Control

Exonuclease: 10 U of Vaccinia virus Capping Enzyme with 1 μg λ-Hind III digest DNA at 37 ℃ for 16 hours yields no degradation as determined by agarose gel electrophoresis.

Endonuclease: 10 U of Vaccinia virus Capping Enzyme with 1 μg λDNA at 37 ℃ for 16 hours yields no degradation as determined by agarose gel electrophoresis.

Nickase: 10 U of Vaccinia virus Capping Enzyme with 1 μg pBR322 at 37 ℃ for 16 hours yields no degradation as determined by agarose gel electrophoresis.

RNase: 10 U of Vaccinia virus Capping Enzyme with 1.6 μg MS2 RNA for 4 hours at 37 ℃ yields no degradation as determined by agarose

gel electrophoresis.

E.coli DNA: 10 U of Vaccinia virus Capping Enzyme is screened for the presence of E. coli genomic DNA using TaqMan qPCR with primers specific for the E. coli 16S rRNA locus. The E. coli genomic DNA contamination is≤0.1 pg/10 U.

Bacterial Endotoxin: LAL-test, according to Chinese Pharmacopoeia IV 2020 edition, gel limit test method, general rule (1143). Bacterial endotoxin content should be ≤10 EU/mg.

Reaction system and conditions

1.  Capping Protocol (reaction volume: 20 μL) This procedure is applicable to the capping reaction of 10μg RNA (≥100 nt) and it can be scaled up according to experimental demands.

1) Combine 10 μg RNA and Nuclease-free H2O in a 1.5 ml microfuge tube to a final volume of 15.0 µL.

2) Heat at 65℃ for 5 minutes followed by ice bath for 5 minutes.

3) Add the following components in the order specified:

KCl, 10 mM MgCl2, 10 mM DTT, (25℃, pH 8.0)

4) Incubate at 37°C for 30 minutes, RNA is now capped and ready for downstream applications.

2. 5′ terminal labeling reaction (reaction volume: 20 μL)

This protocol is designed to label RNA containing a 5´ triphosphate and it can be scaled up according to demands. The efficiency of label incorporation will be impacted by the molar

ratio of RNA: GTP, as well as the GTP content in RNA samples

1) Combine appropriate amount of RNA and Nuclease-free H2O in a 1.5 ml microfuge tube to a final volume of 14.0 µL.

2) Heat at 65℃ for 5 minutes followed by ice bath for 5 minutes.

3) Add the following components in the order specified

** GTP MIX refers to GTP and a small number of markers. For the concentration of GTP, refer to Note 3.

4) Incubate at 37°C for 30 minutes, RNA 5′ end is now labeled and ready for downstream applications.

Notes on use

1. Heating the solution of RNA prior to incubation with the Vaccinia Capping Enzyme removes secondary structure on the 5´ end of the transcript. Extend time to 60 minutes for transcripts with known highly structured 5´ends.

2. RNA used for capping reactions should be purified prior to use and suspended in nuclease-free water. EDTA should not be present and the solution should be free of salts.

3. For labeling the 5´ end, the total GTP concentration should be around 1-3 times the molar concentration of mRNA in there action.

4. The volume of the reaction system can be scaled up or down according to the actual demands.

1. Capping mRNA prior to translation assays/in vitro translation

2. Labeling 5´ end of mRNA